Cited by 594Estrogen and related hormone effectsAdrenal Hormones and DisordersReceptor Mechanisms and Signaling

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Genomic and nongenomic effects of glucocorticoids

Stahn, Cindy, Buttgereit, Frank·2008·Nature Clinical Practice Rheumatology

Open this paper in CoChat — free account

Abstract

The strong anti-inflammatory and immunosuppressive effects of glucocorticoids are mediated primarily by the cytosolic glucocorticoid receptors. These receptors are members of the steroid hormone receptor family, a superfamily of ligand-inducible transcription factors, and exert genomic effects that can result in increased expression of regulatory-including anti-inflammatory-proteins (transactivation), or decreased production of proinflammatory proteins (transrepression). Transactivation is thought to be responsible for numerous adverse effects of glucocorticoids; transrepression is thought to be responsible for many of the clinically desirable anti-inflammatory and immunosuppressive effects of glucocorticoids. Optimized glucocorticoids, such as selective glucocorticoid receptor agonists, are being developed to try to minimize the adverse effects many patients experience. Glucocorticoids also exert their effects via rapid, nongenomic mechanisms that can be classified as involving nonspecific interactions of glucocorticoids with cellular membranes, nongenomic effects that are mediated by cytosolic glucocorticoid receptors, or specific interactions with membrane-bound glucocorticoid receptors. Increased understanding of these mechanisms of glucocorticoid action could enable the development of novel drugs with which to treat patients with inflammatory and autoimmune disease.

Integrity signals

Registry

Crossref · 10.1038/ncprheum0898

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Primary structure and expression of a functional human glucocorticoid receptor cDNA
Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A. E., Lebo, R. V., Thompson, E. B., Rosenfeld, M. G., & Evans, R. M. (1985) · Nature · doi:10.1038/318635a0 · Cited by 1,882
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Oral corticosteroids and fracture risk: relationship to daily and cumulative doses
van Staa, T. P., Leufkens, H. G. M., Abenhaim, L., Zhang, B., & Cooper, C. C. (2000) · Lara D. Veeken · doi:10.1093/rheumatology/39.12.1383 · Cited by 699
Basic Guide to the Mechanisms of Antiestrogen Action
MacGregor, J. I., & Jordan, V. C. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01358-9 · Cited by 698
Steroid hormone receptors: an update
Beato, M. (2000) · Human Reproduction Update · doi:10.1093/humupd/6.3.225 · Cited by 615
Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase
Hafezi‐Moghadam, A., Simoncini, T., Yang, Z., Limbourg, F. P., Plumier, J.-C., Rebsamen, M. C., Hsieh, C.-M., Chui, D.-S., Thomas, K. L., Prorock, A. J., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-473 · Cited by 596
The glucocorticoid receptor inhibits NFκB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain
Nissen, R. M., & Yamamoto, K. R. (2000) · Genes & Development · doi:10.1101/gad.827900 · Cited by 559
Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology
Buttgereit, F., Da Silva, J. A. P., Boers, M., Burmester, G.-R., Cutolo, M., Jacobs, J., Kirwan, J., Köhler, L., van Riel, P., Vischer, T., et al. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.8.718 · Cited by 544
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data
da Silva, J. A. P., Jacobs, J. W. G., Kirwan, J., Boers, M., Saag, K. G., Inês, L. B. S., de Koning, E. J. P., Buttgereit, F., Cutolo, M., Capell, H., et al. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.038638 · Cited by 529
A corticosteroid receptor in neuronal membranes
Orchinik, M., Murray, T. F., & Moore, F. L. (1991) · Science · doi:10.1126/science.2063198 · Cited by 523

Flagged first, then by citations

Show all 65 references

Research works printed but not linked: 1

Bijlsma JW et al. (2007) Systemic and intra-articular glucocorticoids in rheumatoid arthritis. In Rheumatoid arthritis, edn 2, 337–353 (Eds Firestein G. et al.) New York: Oxford University Press

Sorted by citations

Items 401–500 of 592

Evaluation of Cordyceps militaris steroids as anti-inflammatory agents to combat the Covid-19 cytokine storm: a bioinformatics and structure-based drug designing approach
Singh, M., Verma, H., Narendra, G., Raju, B., Choudhary, S., Bhandu, P., & Silakari, O. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2245039 · Cited by 5
“Targeting NR3C1 may give genomic (inhibit cytokine production) as well as non-genomic effects (promoting the production of lipocortin that inhibits phospholipase A2) involving the inhibition of the release of inflammation-related mediators (Stahn et al., 2007; Stahn & Buttgereit, 2008).”
Background
Bone Turnover Markers and Glucocorticoid Treatments
Devogelaer, J., Durnez, A., Gruson, D., & Manicourt, D. H. (2017) · Biomarkers in disease · doi:10.1007/978-94-007-7693-7_23 · Cited by 4
Dexamethasone-induced withdrawal seizure
Mahar, S., & Malhotra, M. (2015) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.155490 · Cited by 4
“[1] It binds to specific receptor proteins in the target tissues to regulate the expression of corticosteroid responsive genes, changing the levels and arrays of proteins synthesized by the various target tissues.[2] Dexamethasone is a commonly used drug used in the treatment of allergic states, dermatological disease…”
Background
Dexamethasone—An Effective Antiemetic, but is it Safe?
Short, T. G., & Leslie, K. (2015) · Anaesthesia and Intensive Care · doi:10.1177/0310057x1504300203 · Cited by 4
Defining the Differential Corticosteroid Response Basis from Multiple Omics Approaches
Ramirez-Falcon, M., Suarez-Pajes, E., & Flores, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413611 · Cited by 3
Could Endogenous Glucocorticoids Influence SARS-CoV-2 Infectivity?
Hardy, E., & Fernández-Patrón, C. (2022) · Cells · doi:10.3390/cells11192955 · Cited by 3
“These findings suggest that endogenous glucocorticoids may play new, potentially important roles in innate immunity through their ability to directly interact with SARS-CoV-2, in addition to their classical mode of action mediated by glucocorticoid receptors which are expressed in almost all cells in the body [1].”
BackgroundInfluential
A morphometric analysis of the retinal arterioles with adaptive optics imaging in RPE65 ‐associated retinal dystrophy after treatment with voretigene neparvovec
Kortuem, C., Kempf, M., Merle, D. A., Kuehlewein, L., Pohl, L., Reith, M., Jung, R., Ott, S., Stingl, K. T., & Štingl, K. (2023) · Acta Ophthalmologica · doi:10.1111/aos.15765 · Cited by 3
Hydroethanolic Extract of Salvia officinalis L. Leaves Improves Memory and Alleviates Neuroinflammation in ICR Mice
Sefah, B., Ashie, Y., Osafo, N., & Mante, P. K. (2025) · The Scientific World JOURNAL · doi:10.1155/tswj/2198542 · Cited by 3
“Prednisolone as a corticosteroid is known to e ﬀ ectively reduce in ﬂ ammation and suppresses immune response [44].”
HYDROCORTISONE SUPRESSES INFLAMMATORY ACTIVITY OF METALLOPROTEINASE-8 IN CAROTID PLAQUE
Gabriel, S. A., Antonângelo, L., Capelozzi, V. L., Beteli, C. B., Júnior, O. D. C., de Aquino, J. L. B., & Caffaro, R. A. (2015) · Brazilian Journal of Cardiovascular Surgery · doi:10.5935/1678-9741.20150034 · Cited by 3
“Glucocorticoids are known for its anti-inflammatory and immunosuppressive properties, reducing the secretion of inflammatory cytokines by monocytes, macrophages and lymphocytes[8,9].”
Background
Fetal maturation revealed by amniotic fluid cell-free transcriptome in rhesus macaques
Schmidt, A. F. S., Schnell, D., Eaton, K. P., Chetal, K., Kannan, P. S., Miller, L. A., Chougnet, C. A., Swarr, D. T., Jobe, A. H., Salomonis, N., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.162101 · Cited by 3
Association of glucocorticoid receptor expression with key members of the insulin signaling pathway and heat shock proteins in the bovine ovary
Rodríguez, F. M., Huber, E., Moreyra, M. L. C., Amweg, A. N., Notaro, U. S., Recce, S., Ormaechea, N. E., Ortega, H. H., Salvetti, N. R., & Rey, F. (2023) · Theriogenology · doi:10.1016/j.theriogenology.2023.08.023 · Cited by 3
Glucocorticoid treatment increases density of serotonin 5-HT2A receptors in humans
Kling, A., Mjörndal, T., & Rantapää‐Dahlqvist, S. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.10.006 · Cited by 3
“Although, no mechanism for an interaction between glucocorticoids and cytoplasmatic 5-HT2A receptors has been described this possibility should not be excluded since glucocorticoids also may exert effects via nongenomic mechanisms (Stahn and Buttgereit, 2008).”
Background
Ostéoporose secondaire à la corticothérapie systémique
Bouvard, B., Legrand, É., Audran, M., & Chappard, D. (2011) · Revue du Rhumatisme Monographies · doi:10.1016/j.monrhu.2011.02.005 · Cited by 3
Cortisone and hydrocortisone inhibit human Kv1.3 activity in a non-genomic manner
Yu, J., Park, M., Choi, S., & Jo, S. (2015) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-015-1109-2 · Cited by 3
“Glucocorticoids also affect various functions via rapid non-genomic mechanisms, which are characterized by large doses, short latency, and lack of transcriptional modulation (Borski 2000; Evanson et al. 2010; Losel and Wehling 2003; Stahn and Buttgereit 2008; Zhou et al. 2011).”
Background
Nongenomic Effects of Glucocorticoids
Gong, H., Liu, L., & Jiang, C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802175-0.00039-5 · Cited by 3
Pharmacology and Clinical Relevance of Commonly Used Drugs
Murinova, N., Krashin, D. L., & Kaye, A. D. (2018) · Springer eBooks · doi:10.1007/978-3-319-60361-2_3 · Cited by 3
EULAR 2023 Recommendations for the Management of Systemic Lupus Erythematosus: One Step Forward
Moysidou, G.-S., & Fanouriakis, A. (2024) · Mediterranean Journal of Rheumatology · doi:10.31138/mjr.130124.erm · Cited by 3
A Single Perioperative Dose of Dexamethasone Is Not Associated With an Increased Risk of Infection in Patients With Hip or Knee Osteoarthritis Considered for Elective Primary Total Hip or Total Knee Arthroplasty
Roškar, S., Levašič, V., Blas, M., & Kovač, S. (2025) · Arthroplasty Today · doi:10.1016/j.artd.2025.101761 · Cited by 2
“However, there are still several concerns about the safety of perioperative corticosteroid administration regarding increased risk for PJI [3,4,15].”
Rethinking corticosteroid therapy in autoimmune neurology
Teoh, C. S. C., Dubey, S., & Handel, A. E. (2025) · Brain · doi:10.1093/brain/awaf292 · Cited by 2
Soft Glucocorticoids: Eye-Targeted Chemical Delivery Systems (CDSs) and Retrometabolic Drug Design: A Review
Chowdhury, P., & Borah, J. M. (2012) · InTech eBooks · doi:10.5772/48380 · Cited by 2
“Glucocorticoids also mediate antiinflammatory activity through membrane-bound GR-mediated nongenomic effects and also through direct non specific interaction with cellular membranes [3, 4].”
Immunsuppression und Ergebnisse in der Nierentransplantation
Paliege, A., Bamoulid, J., Bachmann, F., Staeck, O., Halleck, F., Khadzhynov, D., Brakemeier, S., Dürr, M., & Budde, K. (2015) · Der Urologe · doi:10.1007/s00120-015-3909-x · Cited by 2
A non-transcriptional role for the glucocorticoid receptor in mediating the cell stress response
Ptushkina, M., Poolman, T. M., Iqbal, M., Ashe, M., Petersen, J., Woodburn, J., Rattray, M., Whetton, A. D., & Ray, D. W. (2017) · Scientific Reports · doi:10.1038/s41598-017-09722-z · Cited by 2
Glucocorticoid-induced osteoporosis in systemic lupus erythematosus
Phang, K. F., Cho, J., Lee, W., & Mak, A. (2018) · Rheumatology Practice and Research · doi:10.1177/2059902118802510 · Cited by 3
Comparative analysis between the safety and efficacy of oral corticosteroids versus corticosteroids pulse therapies in IgA nephropathy
Wang, Y., Huang, N., Wang, Y., Jiang, Y., Yimamuyushan, A., Xia, X., Fan, L., Yu, J., He, J., Chen, W., et al. (2023) · Renal Failure · doi:10.1080/0886022x.2023.2255683 · Cited by 3
“…the Mannheim classification of rapid nongenomic mechanisms of corticosteroid action includes three major categories: nonspecific interactions of corticosteroids with cellular membranes; nongenomic effects mediated by the cGcR; and specific interactions with membrane-bound cGcR [38– 40].”
Background
Eco-endocrinological dynamics: Unraveling dexamethasone's influence on the interrenal axis in juvenile carp Cyprinus carpio
Gutiérrez-Noya, V. M., Gómez‐Oliván, L. M., Orozco-Hernández, J. M., Rosales-Pérez, K. E., Casas-Hinojosa, I., Elizalde-Velázquez, G. A., García-Medina, S., Galar‐Martínez, M., & Orozco-Hernández, L. A. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.172947 · Cited by 2
Research Highlights
Tullar, C., & Issa, F. (2019) · Transplantation · doi:10.1097/tp.0000000000002666 · Cited by 2
Prevention and treatment of glucocorticoid-induced osteoporosis in International and Italian scenarios
Munno, O. D., & Sedie, A. D. (2011) · Reumatismo · doi:10.4081/reumatismo.2011.67 · Cited by 2
Mechanisms of the Analgesic Action of Corticotrophin-Releasing Factor on Somatic Pain Sensitivity in Rats
Yarushkina, N. I., Bagaeva, T. R., & Filaretova, L. P. (2015) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-015-0095-7 · Cited by 2
“Published data indicate that the glucocorticoid hormones may exert their influences by the classical genomic mechanism via effects on the genetic apparatus of the cell, which can start to appear from 10–30 min [48].”
Background
Role of C-fibers during acute and chronic stress on formalin-induced paw edema in rats.
Sepehri, Z., Fereidoni, M., & Niazmand, S. (2012) · PubMed · Cited by 2
High-dose glucocorticoid treatment of near-fatal bocavirus lung infection results in rapid recovery
Obenaus, M., Schildgen, O., Schürmann, D., von Brünneck, A., Janz, M., Keller, U. B., Gebauer, B., Schilling, J., Schwartz, S., Weißbrich, B., et al. (2021) · ERJ Open Research · doi:10.1183/23120541.00060-2021 · Cited by 2
“We are aware of GT-induced side effects, that corticosteroid treatment of ARDS- or severe acute respiratory syndrome (SARS)-patients or patients suffering from viral pneumonia has generated conflicting results [4][5][9][10][11], and that prolonged intake of corticosteroids predisposes for invasive aspergillosis in the…”
BackgroundResult
Systemic glucocorticoids in rheumatology
Saag, K. G. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-06551-1.00051-8 · Cited by 2
Arthritic Conditions Affecting the Temporomandibular Joint
Mercuri, L. G., & Abramowicz, S. (2019) · Springer eBooks · doi:10.1007/978-3-319-72303-7_32 · Cited by 2
Arthritic Conditions Affecting the Temporomandibular Joint
Mercuri, L. G., & Abramowicz, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-28100-1_32-2 · Cited by 2
Derinat® has an immunomodulatory and anti-inflammatory effect on the model of acute lung injury in male SD rats
Palikova, Y. A., Паликов, В. А., Novikova, N. I., Слащева, Г. А., Rasskazova, E. A., Tukhovskaya, E. A., Danilkovich, A. V., Dyachenko, I. A., Belogurov, A. A., Kudriaeva, A. A., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1111340 · Cited by 2
“, as well as and other regulatory proteins that affect metabolism (Rhen and Cidlowski, 2005; Stahn and Buttgereit 2008), and also inhibits transcription of inflammatory transcription factor proteins such as NF-κB andactivatorprotein-1 (AP-1) The described processes are the main mechanism of antiinflammatory and immuno…”
Background
Neurosteroid, Natural and Anabolic Steroids: Physiological, Immunological and Histopathological Study on Diabetic Albino Rats
Barany, Q., Sofi, A. M. S., & Al-Barwary, M. (2023) · Egyptian Journal of Veterinary Science · doi:10.21608/ejvs.2023.205247.1486 · Cited by 2
“testosterone treated animals showed highly significant reduction in WBCs count compared with the diabetic control group that could be due to the actions of glucocorticoids including the inhibition of leukocytes movement and access of these cells to the site of inflammation as reported by Stahn & Buttgereit, (2008), mo…”
Method
Evaluating as-needed inhaled corticosteroid strategies in asthma: expanding the benefits to mild asthma
Bigoni, T., Alfano, F., Baraldi, F., Contoli, M., & Papi, A. A. (2023) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2023.2247973 · Cited by 2
Facial transplantation as an option in reconstructive surgery: no mountains too high?
Błogowski, W. (2009) · ANZ Journal of Surgery · doi:10.1111/j.1445-2197.2009.05140.x · Cited by 2
[Topics of glucocorticoids--centered on therapy for rheumatoid arthritis].
Akama, H. (2011) · Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology · doi:10.2177/jsci.34.464 · Cited by 2
Immunomodulatory, Immunoablative, and Biologic Therapies
van Laar, J. M., & Simms, R. W. (2016) · Springer eBooks · doi:10.1007/978-3-319-31407-5_41 · Cited by 2
What determines the effectiveness and safety of topical treatment of hemorrhoids
Духанин, А. С. (2017) · Pirogov Russian Journal of Surgery · doi:10.17116/hirurgia201710113-119 · Cited by 2
“Таким образом, к особенностям ГКС относится уникальный двойной механизм подавления воспаления [8] (рис.”
Rapid and Nongenomic Glucocorticoid Signaling in Rainbow Trout
Dindia, L. A. (2013) · UWSpace (University of Waterloo) · Cited by 2
Current trends in postsurgical management of ocular inflammation following cataract surgery
Donnenfeld, E. D. (2014) · Expert Review of Ophthalmology · doi:10.1586/17469899.2015.996548 · Cited by 1
“This process is thought to be responsible for the numerous adverse effects of GCs [40].”
Background
Experimental Study of Therapeutic Efficacy of the Topical Preparation «Kourochitin» in Skin Allergy
Климович, А. А., Styshova, O. N., Popov, A. M., Moskvina, T. V., Tsybulsky, A. V., Derunov, D. A., & Stonik, V. A. (2020) · Letters in Drug Design & Discovery · doi:10.2174/1570180817666200316155643 · Cited by 1
Acute encephalopathy associated with severe fever with thrombocytopaenia syndrome
Fujita, M., Nakano, Y., Honda, H., & Hagiya, H. (2020) · BMJ Case Reports · doi:10.1136/bcr-2020-240075 · Cited by 1
“…glucocorticoid may be commonly administered for virus-associated encephalopathy with the expectation of inhibiting cytokine production and function, 6 its effectiveness is yet to be established; some literatures reporting effectiveness of the steroid therapy in acute encephalopathy 7 8 and others…”
Plasma exchange alone versus combination with intravenous immunoglobulin/methylprednisolone pulse therapy in severe systemic rheumatic diseases: a retrospective study
Guo, J., Li, S., Xu, H. Y., Wang, X., Luo, W., Sun, J., Li, J., Chen, Z., Lu, G., Huang, X., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1454691 · Cited by 1
“Methylprednisolone binds to glucocorticoid receptor (GR) to exert anti-in ﬂ ammatory effect via regulating leukocyte migration, immune cell activation, and proin ﬂ ammatory cytokine production (24).”
Cataract surgery: rational algorithm of postoperative examination of patients
Nikolaenko, V. P., Belov, D. F., & Аntonova, А. V. (2024) · Ophthalmology Reports · doi:10.17816/ov635529 · Cited by 1
Effect of antiemetic corticosteroids on the development of immune-related adverse events caused by chemoimmunotherapy: a multicenter retrospective study
Fujimoto, A., Koutake, Y., Tsutsui, Y., Nakahara, M., Matsuo, K., Yabuuchi, Y., Kamimura, G., Kawamata, Y., Uehara, T., Ikari, A., et al. (2025) · Supportive Care in Cancer · doi:10.1007/s00520-025-09268-1 · Cited by 1
“Glucocorticoids primarily induce immunosuppressive and anti-inflammatory effects by binding to the glucocorticoid receptor and the subsequent direct or indirect genomic interactions [33].”
Barriers and motivations to exercise participation among women with severe systemic lupus erythematosus who have recently undergone glucocorticoid pulse therapy: A qualitative analysis
Barboza, J. M., Esteves, G. P., Ribeiro, W. J. D., Fickert, V. R., Franco, A. S., Seguro, L. P. C., Roschel, H., Gualano, B., & Dolan, E. (2025) · Lupus · doi:10.1177/09612033251330116 · Cited by 1
“15 To the best of our knowledge, however, no research has evaluated barriers and motivations to exercise participation in this population.”
Controversies of and Indications for Use of Glucocorticoids in the Intensive Care Unit and the Emergency Room
Buriko, Y., & Tinsley, A. (2025) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2025.01.007 · Cited by 1
Glucocorticoid-induced osteoporosis in children: emerging vascular and molecular targets
Barik, S. K., & Crane, J. L. (2025) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000001476 · Cited by 2
Hormones and RNP granules – crosstalk in gene regulation across species
Giannios, P. (2025) · Journal of Cell Science · doi:10.1242/jcs.264150 · Cited by 1
Advances of microneedle technology for the treatment of autoimmune diseases
Chen, Y., Fu, Y., Wen, X., Chen, M., Dian, L., Peng, T., Wu, C., Lu, C., & Quan, G. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.01.003 · Cited by 1
“Due to their higher dosages and extensive systemic distribution, systemic glucocorticoids have a broader array of adverse effects, including weight gain, osteoporosis, and immunosuppression 28 .”
SGK1 signaling: an important modulator of CFTR function and early immune response in mouse intestine
Muiler, C., Santos, A. K., & Ameen, N. A. (2026) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00400.2025 · Cited by 1
Development and validation of a risk score for serious infection in patients with rheumatic diseases receiving prolonged high-dose glucocorticoids
Choi, S. R., Kim, J. Y., Ha, Y., Park, J. K., Kang, E. H., Lee, Y. J., Lee, E. B., Lee, E. Y., & Park, J. W. (2026) · Arthritis Research & Therapy · doi:10.1186/s13075-026-03756-3 · Cited by 1
“GCs mainly exert immunosuppressive effects by altering the transcription of genes encoding proinflammatory cytokines, chemo-kines, cell adhesion molecules, and key enzymes involved in host inflammatory reactions [3, 4].”
Corticosteroids in immunocompromised ICU patients with pneumonia: risks, evidence, and clinical practice
Olivera, J., Ramírez, P. O. N., Bustos, I. G., Martinez-Lemus, L. F., Sanabria-Herrera, N., Serrano-Mayorga, C. C., Aguirre-Gutierrez, V., Forero-Delgadillo, A. J., Méndez-Castillo, L., Montaño, G. S., et al. (2026) · Pneumonia · doi:10.1186/s41479-026-00202-5 · Cited by 1
“Within this already dysregulated immune environment, systemic corticosteroids act as an additional immunologic modulator, exerting pleiotropic effects through genomic and non-genomic mechanisms [50, 51].”
The aspiration of precision glucocorticoid pharmacotherapy in immune-mediated diseases: where do we stand in integrating pharmacogenomics and biomarkers for individualized treatment?
Colina, M., & Campana, G. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1889058 · Cited by 1
“The genomics revolution has revealed that genetic polymorphisms account for 20% – 95% of variability in drug response across therapeutic classes (6).”
Influential
The Glucocorticoid Antagonist RU-486 Suppresses HIV Infectivity and Replication
Benton, T. D., Lynch, K. G., Dubé, B., Gettes, D. R., Tustin, N. B., Metzger, D. S., Blume, J., Douglas, S. D., & Evans, D. L. (2013) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.12060147 · Cited by 1
“Treatment of MDMs with RU-486 significantly downregulated HIV RT activity at the first time-point (Day 4; t[35] 5 22.”
Background
Methylprednisolone Pulse Therapy for Nonresponders to Immunoglobulin Therapy
Miura, M. (2016) · Springer eBooks · doi:10.1007/978-4-431-56039-5_18 · Cited by 1
Drug-Induced Hypertension in Chronic Kidney Disease
Vichot, A. A., & Perazella, M. A. (2016) · Springer eBooks · doi:10.1007/978-1-4939-6436-9_12 · Cited by 1
Immunomodulatory Therapies for Interstitial Cystitis/Bladder Pain Syndrome
Akiyama, Y., & Homma, Y. (2020) · Current Bladder Dysfunction Reports · doi:10.1007/s11884-020-00593-1 · Cited by 1
Glukokortikoide in der Therapie der Riesenzellarteriitis
Hellmich, B. (2021) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-021-00975-8 · Cited by 1
Glucocorticoids Immunotropic Effects Realization: the Role of Glucocorticoid Receptors, Transport and Regulatory Systems. The Literature Review
Голюченко, О. А., & Стефанович, О. С. (2022) · Рецепт · doi:10.34883/pi.2022.25.3.006 · Cited by 1
The nature and origin of immunosuppressive disorders
Boeva, E. V., Рассохин, В. В., Belyakov, N. А., & Simbirtsev, A. S. (2024) · HIV Infection and Immunosuppressive Disorders · doi:10.22328/2077-9828-2023-15-4-7-24 · Cited by 1
Revisit the Inhibitory Effects of Glucocorticoids on Immunocytes
Wu, S., Zhao, S., Zhong, Y., & Wang, B. (2024) · Fortune Journal of Health Sciences · doi:10.26502/fjhs.159 · Cited by 1
In-hospital survival of critically ill COVID-19 patients treated with glucocorticoids: a multicenter real-world data study
Angermair, S., Hardenberg, J.-H., Rubarth, K., Balzer, F., Akbari, N., Menk, M., Spies, C., Eckardt, K., Poddubnyy, D., Siegmund, B., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-62302-w · Cited by 1
Clinical association of FKBP5 gene in systemic lupus erythematosus patients
Tahri, S., Abida, O., Elloumi, N., Hachicha, H., Charfi, S., Marzouk, S., Kammoun, K., Bahloul, Z., Boudawara, T., Masmoudi, H., et al. (2024) · Gene Reports · doi:10.1016/j.genrep.2024.101948 · Cited by 1
Glucocorticoid boluses followed by tocilizumab in giant cell arteritis patients: effects on peripheral blood monocytes and lymphocytes
Catellani, C., Bonacini, M., Rossi, A., Ferrigno, I., Buia, V., Marvisi, C., Cassone, G., Catanoso, M., Tommaso, G. D., Boiardi, L., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1516008 · Cited by 1
“Non-genomic effects derive from: (1) interactions with cellular membranes; (2) membrane-bound GC receptors; and (3) cytosolic GC receptors (22).”
The Use of Glucocorticoids in the Treatment of Acute Asthma Exacerbations
Abdullah, A. (2012) · InTech eBooks · doi:10.5772/53221 · Cited by 1
“Moderate doses (7.5 mg – 30 mg/day) are usually associated with significant adverse effects, and high doses (30 mg – 100 mg) may be associated with serious adverse effects (Stahn & Buttgereit, 2008).”
BackgroundInfluential
Hidrocortisona reduz as concentrações séricas dos biomarcadores inflamatórios séricos em pacientes submetidos a endarterectomia de carótida
Gabriel, S. A., Antonângelo, L., Capelozzi, V. L., Beteli, C. B., de Camargo, O., de Aquino, J. L. B., & Caffaro, R. A. (2015) · Jornal Vascular Brasileiro · doi:10.1590/1677-5449.0022 · Cited by 1
“36% (8) had from 50% to 69% stenosis, and 9.”
Bone Turnover Markers and Glucocorticoid Treatments
Devogelaer, J., Durnez, A., Gruson, D., & Manicourt, D. H. (2015) · Exposure and Health · doi:10.1007/978-94-007-7745-3_23-1 · Cited by 1
Metilprednisolona en brotes de enfermedades inmunomediadas: relación entre dosis, efectividad y seguridad. Estudio Piloto
Galdo, Á. D. (2017) · Revista de la Facultad de Ciencias Médicas de Córdoba · doi:10.31053/1853.0605.v74.n4.16460 · Cited by 1
Psoriasis: the choice of optimal topical corticosteroid drug
Bolotna, L. А. (2019) · Ukrainian Journal of Dermatology Venerology Cosmetology · doi:10.30978/ujdvk2019-1-55 · Cited by 1
Basic and clinical aspects of glucocorticoid action in bone
Zhou, H., Cooper, M. S., & Seibel, M. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00039-7 · Cited by 1
Pattern of Self-Medication with Prescription Medicines Among Residents of Ilorin in North Central Nigeria
Jamiu, M. O., Fatima, A. I., & Onozare, A. F. (2020) · RADS Journal of Pharmacy and Pharmaceutical Sciences · doi:10.37962/jpps.v7i4.353 · Cited by 2
“It binds to specific receptor proteins in the target tissues to regulate the expression of corticosteroid responsive genes, changing the levels and arrays of proteins synthesized by the various target tissues [12, 13].”
Background
Relación entre el uso de glucocorticoides y el daño crónico en Lupus Eritematoso Sistémico: una asociación precoz y nociva. Estudio exploratorio.
Danza, Ã., Narváez, J., Graña, D., Pérez, L., Viera, A., Baccelli, A., Borgia, I., & Rocca, F. (2021) · Revista Uruguaya de Medicina Interna · doi:10.26445/06.01.2 · Cited by 1
Applications of Corticosteroid Therapy in Inflammatory Rheumatic Diseases
Mușetescu, A. E., Criveanu, C., Bobirca, A. V., Florescu, A., Bumbea, A. M., & BOBIRCA, F. T. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98720 · Cited by 1
Ventilatory support and corticosteroid therapy in SARS-CoV-2
Martínez‐Sagasti, F., Blanco, A. P., García-Perrote, S. C., & Alonso-Martínez, P. (2021) · Revista Española de Quimioterapia · doi:10.37201/req/s01.16.2021 · Cited by 1
“Very high doses of steroids cannot be used as long-term therapy due to their serious adverse effects [2].”
Background
Role of adipokines in the pathophysiology of coronary artery disease
Kumari, R., Kumar, S., Vyavahare, S. S., Srivastava, R., & Srivastava, S. P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99521-4.00021-0 · Cited by 1
Glucocorticoid-free Treatment of Systemic Lupus Erythematosus: Is it Feasible?
Shaharir, S. S., Gordon, C., & Reynolds, J. A. (2023) · Indian Journal of Rheumatology · doi:10.4103/injr.injr_97_22 · Cited by 1
“[28,30] The nongenomic effects occur as a result of interaction between a higher concentration of GC (prednisone equivalent dose of >100 mg/day) with membrane‑bound receptors or directly with the membrane which leads to inhibition of arachidonic acid release.”
Efeito da suplementação com leucina sobre a resposta atrófica da musculatura esquelética induzida pelo uso de dexametasona
Zanchi, N. E. (2011) · doi:10.11606/t.39.2011.tde-09052011-100300 · Cited by 1
Itch
Reszke, R., & Szepietowski, J. C. (2019) · Wiley eBooks · doi:10.1002/9781119476009.ch13 · Cited by 1
Examination of the effect of weaning stress on the physiological and molecular regulation of immune function in circulating bovine leukocytes
O’Loughlin, A. (2011) · Maynooth University ePrints and eTheses Archive (Maynooth University) · Cited by 1
Ocular Corticosteroids
Nakhla, E., & Gelot, S. R. (2014) · Springer eBooks · doi:10.1007/978-1-4614-9194-1_239 · Cited by 1
Role of Ion Channels and Exchangers in the Regulation of Dendritic Cells
Heise, N. (2010)
Hormones, Part 1: Thyroid and Corticosteroid Hormones
Hong, J. C. (2014) · Springer eBooks · doi:10.1007/978-1-4614-8948-1_19
Optimising glucocorticoid therapy in rheumatic diseases : an incompatible triangle?
Hoes, J. N. (2011) · Utrecht University Repository (Utrecht University)
POLYMYOSITIS AND DERMATOMYOSITIS - INFLAMMATION, MUSCLE STRUCTURE & IMMUNOSUPPRESSIVE TREATMENT
Loell, I. (2012)
The history of glucocorticoids and its introduction to dentistry
Beisland, K. S. (2013) · NORA - Norwegian Open Research Archives
Glucocorticoid Treatment for Cochlear Ischemic and Acoustic Injuries
Tabuchi, K., & Hara, A. (2010) · Nippon Jibiinkoka Gakkai Kaiho · doi:10.3950/jibiinkoka.113.831
T CELL SUBSETS AND DISEASE MECHANISMS IN INFLAMMATORY MYOPATHIES
Pandya, J. M. (2014) · Figshare
Glucocorticoid Sensitivity in Rheumatoid Arthritis
Quax, R. A. M. (2013) · EUR Research Repository (Erasmus University Rotterdam)
Effects of glucocorticoids in macrophages
Jubb, A. W. (2015) · ERA
The glucocorticoid receptor plays a central role in mammalian reproduction and signal integration in pituitary gonadotropes
Wehmeyer, L. (2015) · Open University of Cape Town (University of Cape Town)
Fizjologia i molekularny mechanizm działania glikokortykoidów* Physiology and molecular mechanism of glucocorticoid action
Nagalski, A., & Kiersztan, A. (2010)
Efeito modulatório de fatores de virulência de Porphyromonas gingivalis sobre os receptores B1 para as cininas na pata de rato
Dornelles, F. N. (2009) · Americanae (AECID Library)
Verlauf der zellulären Immunantwort bei Lebendnierenempfängern - Messung von IFN-γ und IL-17 im Elispot-Assay
Grehn, C. (2015) · Qucosa (Saxon State and University Library Dresden)
Hydrocortisone supresses inflammatory activity of metalloproteinase - 8 in carotid plaque Hidrocortisona suprime a atividade inflamatória da metaloproteinase - 8 presente na placa carotídea
Gabriel, S. A., Antonângelo, L., Capelozzi, V. L., Júnior, O. D. C., Luís, J., & Caffaro, R. A. (2015)
Mulig interaksjon mellom NMDA reseptorsubenheten 3A og glukokortikoidreseptoren
Feng, Y. (2009) · NORA - Norwegian Open Research Archives
Prevenzioneetrattamentodell'osteoporosi indottadaglucocorticoidinellarealtà ItalianaeinquellaInternazionale Prevention and treatment of glucocorticoid-induced osteoporosis in International and Italian scenarios
Munno, O. D., & Sedie, A. D. (2011)
Systemische Glukokortikoide bei Hauterkrankungen
Ehrchen, J. M. (2015) · CME · doi:10.1007/s11298-015-1099-x
“[1] Stahn C, Buttgereit F (2008) Genomic and nongenomic eff ects of glucocorticoids.”
Background

Authors: Stahn, C., & Buttgereit, F.
Affiliations: Charité – Universitätsmedizin Berlin (DE)
Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
Corresponding author: Buttgereit, Frank
ORCID: Buttgereit, Frank
Venue: Nature Clinical Practice Rheumatology
Publisher: Springer Science and Business Media LLC
Published: 2008-09-02
Volume: 4
Issue: 10
Pages: 525-533
ISSN: 1745-8382 (ISSN-L)
1745-8390
DOI: 10.1038/ncprheum0898
OpenAlex: W1968436319
Cited by: 594
References: 65
Citations by year: 2026: 19 · 2025: 26 · 2024: 29 · 2023: 40 · 2022: 49 · 2021: 33 · 2020: 46 · 2019: 40 · 2018: 26 · 2017: 35 · 2016: 27 · 2015: 37 · 2014: 41 · 2013: 31 · 2012: 29
FWCI: 2.66
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Clinical Practice Rheumatology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords: glucocorticoids, glucocorticoid receptor, genomic mechanisms, transcriptional activation, transrepression, steroid hormone receptors, selective glucocorticoid receptor agonists, adverse effects, anti-inflammatory activity, immunosuppression, rheumatic diseases
MeSH terms: Anti-Inflammatory Agents, Cell Membrane, Dose-Response Relationship, Drug, Glucocorticoids, Humans, Immunosuppressive Agents, Ligands, Receptors, Glucocorticoid, Rheumatology, Transcriptional Activation, Genomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Genomic and nongenomic effects of glucocorticoids

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks